UK Companies House feature
ZOLL MEDICAL UK LIMITED
Cash
£9M
+33.8% vs 2020
Net assets
£12M
+11.5% vs 2020
Employees
63
+16.7% vs 2020
Profit before tax
£1M
+264.4% vs 2020
Profile
- Company number
- 02823225
- Status
- Active
- Incorporation
- 1993-06-02
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86220
- Hubs
- UK Healthcare
Net assets
2-year trend · vs UK Healthcare median
Accounts
2-year trend · latest 2021-03-31
| Metric | Trend | 2020-03-31 | 2021-03-31 |
|---|---|---|---|
| Turnover | £23,204,682 | £35,244,248 | |
| Operating profit | £286,568 | £1,559,038 | |
| Profit before tax | £409,152 | £1,490,824 | |
| Net profit | — | — | |
| Cash | £7,009,099 | £9,377,267 | |
| Total assets less current liabilities | £10,401,697 | £11,600,263 | |
| Net assets | £10,401,697 | £11,600,263 | |
| Equity | £10,401,697 | £11,600,263 | |
| Average employees | 54 | 63 | |
| Wages | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries and on the basis outlined in note 2.3 to the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.”
Subsidiaries
- Itamar Medical UK Limited · 100% held · UK · business providing sleep-apnea testing and diagnostic support using peripheral arterial tonometry (PAT) technology
Significant events
- “There have been no significant events affecting the company since the reporting date.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ROBERTS, Angharad | Secretary | 2023-09-19 | — | — |
| KNELL-MOORE, Richard Andrew | Director | 2016-09-01 | Feb 1976 | English |
| PRITCHARD, Kevin | Director | 2024-09-10 | Oct 1968 | British |
| WHITE, Elijah | Director | 2019-02-18 | Aug 1973 | American |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JENNINGS, Michael | Secretary | 2002-06-26 | 2004-11-12 |
| YOUNG, David Brian | Secretary | 2007-01-01 | 2023-09-19 |
| MITRE SECRETARIES LIMITED | Corporate Nominee Secretary | 1993-06-02 | 2002-06-26 |
| TAYLOR WESSING SECRETARIES LIMITED | Corporate Secretary | 2004-11-12 | 2007-01-01 |
| BORST, Fredrik Jacob | Director | 1993-10-01 | 1999-08-10 |
| DE SISTO, Duane | Director | 1993-10-01 | 1995-08-24 |
| DOUSSET, Graeme Clark | Director | 2004-06-01 | 2005-03-01 |
| JENNINGS, Michael | Director | 2002-10-01 | 2004-11-12 |
| JONES, Emroy John | Director | 1999-12-01 | 2005-03-01 |
| MELIESTE, Ronald | Director | 2005-03-01 | 2007-10-18 |
| MOGHADAM, Alex | Director | 2005-03-01 | 2013-07-15 |
| PACKER, Richard | Director | 1996-10-01 | 2005-03-01 |
| REEVES, Barbara | Nominee Director | 1993-06-02 | 1993-10-01 |
| SMITH, Stephen Jonathan | Director | 2000-08-08 | 2004-06-28 |
| STUTZ, Rolf | Director | 1993-11-01 | 1999-11-15 |
| WEBSTER, Mark Christopher | Director | 2005-03-01 | 2023-05-26 |
| WHITON, A Ernest | Director | 2002-10-01 | 2019-02-18 |
| WINDMILL, Robert John | Nominee Director | 1993-06-02 | 1993-10-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Zoll Medical Corporation | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 126 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-16 | AA | accounts | accounts with accounts type full |
| 2025-06-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-03-07 | AA | accounts | accounts with accounts type full |
| 2024-09-12 | AP01 | officers | appoint person director company with name date |
| 2024-07-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-01-10 | AA | accounts | accounts with accounts type full |
| 2023-09-19 | AP03 | officers | appoint person secretary company with name date |
| 2023-09-19 | TM02 | officers | termination secretary company with name termination date |
| 2023-06-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-06-12 | TM01 | officers | termination director company with name termination date |
| 2023-01-07 | AA | accounts | accounts with accounts type full |
| 2022-06-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-04-08 | AAMD | accounts | accounts amended with accounts type full |
| 2022-03-28 | AA | accounts | accounts with accounts type total exemption full |
| 2021-06-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-03-25 | AA | accounts | accounts with accounts type full |
| 2020-06-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-12-23 | AA | accounts | accounts with accounts type full |
| 2019-06-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-02-18 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ (private-firm) · reference 2021-03-31
6.13
SAFE
Altman Z″
- Working capital / Total assets 0.578 × 6.56 = +3.79
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.084 × 6.72 = +0.57
- Book equity / Total liabilities 1.691 × 1.05 = +1.78
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory